These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 18380383

  • 1. [Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus].
    de Mulder PH, Haanen JB, Sleijfer S, Kruit WH, Gietema JA, Richel DJ, Groenewegen G, Voest EE, van den Eertwegh AJ, Osanto S, Jansen RL, Mulders PF.
    Ned Tijdschr Geneeskd; 2008 Feb 16; 152(7):371-5. PubMed ID: 18380383
    [Abstract] [Full Text] [Related]

  • 2. Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.
    Pouessel D, Culine S.
    Expert Rev Anticancer Ther; 2006 Dec 16; 6(12):1761-7. PubMed ID: 17181490
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeted therapy for metastatic renal cell carcinoma.
    Motzer RJ, Bukowski RM.
    J Clin Oncol; 2006 Dec 10; 24(35):5601-8. PubMed ID: 17158546
    [Abstract] [Full Text] [Related]

  • 7. New therapies in renal cell carcinoma.
    Patard JJ, Pouessel D, Culine S.
    Curr Opin Support Palliat Care; 2007 Oct 10; 1(3):174-9. PubMed ID: 18685359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeted therapies in metastatic renal cancer in 2009.
    Bastien L, Culine S, Paule B, Ledbai S, Patard JJ, de la Taille A.
    BJU Int; 2009 May 10; 103(10):1334-42. PubMed ID: 19338565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metastatic renal cell cancer treatments: an indirect comparison meta-analysis.
    Mills EJ, Rachlis B, O'Regan C, Thabane L, Perri D.
    BMC Cancer; 2009 Jan 27; 9():34. PubMed ID: 19173737
    [Abstract] [Full Text] [Related]

  • 14. Major treatment improvements encourage kidney cancer researchers to seek further gains.
    Tuma RS.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1202-3. PubMed ID: 18728277
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Renal cell carcinoma and antiangiogenic therapies].
    Pouessel D, Culine S, Verhoest G, Patard JJ.
    Presse Med; 2008 Apr 03; 37(4 Pt 2):628-33. PubMed ID: 18035517
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.